Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-01-31FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr.Reddy's Laboratories Ltd.)
FDA approved a supplemental application for Lansoprazole from Dr. Reddy's Laboratories Ltd.
-
CLINICAL_TRIALS research · 2012-01-26Clinical Trial Update: Impact of GERD on Daily Life (NIS)
AstraZeneca-sponsored clinical trial focusing on the impact of gastroesophageal reflux disease on daily life has completed, providing an upd…
-
FDA approval · 2012-01-20FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2012-01-20FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) from AstraZeneca, updating the labeling under a supplemental…
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures [NA]
A clinical trial comparing two laparoscopic anti-reflux procedures for gastroesophageal reflux disease has completed. Sponsored by Swedish M…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-01-18Clinical Trial Update: Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD [Phase 3]
A Phase 3 trial evaluating double-dose rabeprazole for symptom control in non-erosive gastroesophageal reflux disease was withdrawn.
-
FDA approval · 2012-01-17FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Pantoprazole Sodium by Torrent Pharmaceuticals Limited. The approval denotes changes under a sup…
-
FDA approval · 2012-01-17FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for Pantoprazole Sodium by Lannett Company, Inc., authorizing the continued market approval of a gen…
-
CLINICAL_TRIALS trial_result · 2012-01-12Clinical Trial Update: Efficacy Study of Ilaprazole to Treat Erosive Esophgitis [Phase 3]
Phase 3 efficacy study of ilaprazole for erosive esophagitis and GERD has completed.
-
FDA approval · 2012-01-11FDA Approved: PANTOPRAZOLE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for pantoprazole submitted by NorthStar RxLLC.
-
CLINICAL_TRIALS trial_result · 2012-01-09Clinical Trial Update: Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease [NA]
A completed clinical trial assessed the effect of a very low carbohydrate diet on gastroesophageal reflux disease in overweight individuals.
-
CLINICAL_TRIALS trial_result · 2011-12-29Clinical Trial Update: Esophageal Calibration During Laparoscopic Fundoplication Reduces Dysphagia [NA]
The completed trial indicates that calibrating the esophagus during laparoscopic fundoplication reduces postoperative dysphagia. This surgic…
-
CLINICAL_TRIALS trial_result · 2011-12-28Clinical Trial Update: Study Evaluating Pantoprazole in Children With GERD [Phase 3]
A Phase 3 pediatric trial evaluating pantoprazole for gastroesophageal reflux disease in children has completed, with results posted.
-
FDA approval · 2011-12-15FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Nexium (esomeprazole magnesium) from AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2011-12-15Clinical Trial Update: Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy [NA]
Completed trial update evaluating which supraesophageal reflux symptoms reliably respond to proton-pump inhibitor therapy in gastroesophagea…
-
FDA approval · 2011-12-07FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for Oceanside Pharmaceuticals' omeprazole and sodium bicarbonate, updating labeling through a supple…
-
FDA approval · 2011-12-07FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application to authorize the intravenous form of Protonix (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfiz…
-
CLINICAL_TRIALS trial_result · 2011-11-21Clinical Trial Update: Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease [Phase 2, Phase 3]
Phase 2/Phase 3 trial of famotidine in non-erosive gastroesophageal reflux disease has completed.
-
FDA approval · 2011-10-31FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfizer).
-
FDA approval · 2011-10-28FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID SOLUTAB (lansoprazole) submitted by Takeda Pharmaceuticals America, Inc. The action…
-
FDA approval · 2011-10-28FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Dexilant (dexlansoprazole) by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS research · 2011-10-18Clinical Trial Update: Full-Thickness-Gastroplication For The Treatment Of Gastroesophageal Reflux Disease GERD [NA]
Clinical trial update on full-thickness gastroplication for treating gastroesophageal reflux disease (GERD); current status is unknown.
-
CLINICAL_TRIALS trial_result · 2011-09-21Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD) [Phase 2]
A Phase 2 study evaluating the safety, tolerability and pharmacodynamics of pumosetrag in patients with gastroesophageal reflux disease, whi…
-
CLINICAL_TRIALS trial_result · 2011-09-21Clinical Trial Update: Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease [Phase 3]
A Phase 3 efficacy trial evaluating AGSPT201 tablets for gastroesophageal reflux disease has completed.
-
FDA approval · 2011-08-29FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
FDA approved a supplemental application for Prilosec OTC (omeprazole magnesium) from The Procter & Gamble Manufacturing Company to support O…